Literature DB >> 2900052

Regional distribution of pre- and postsynaptic glutamatergic function in Alzheimer's disease.

R Cowburn1, J Hardy, P Roberts, R Briggs.   

Abstract

Ca2+/Cl- -independent L-[3H]glutamate- and sodium-dependent D-[3H]aspartate binding assays were used to assess the integrity of N-methyl-D-aspartate (NMDA) receptors and glutamate uptake sites in a number of areas from control and Alzheimer's diseased brain. NMDA receptor densities were unchanged in all areas tested. In contrast, significant reductions in the number of glutamate terminals were seen in the hippocampus of the Alzheimer's samples. A smaller reduction was seen in the caudate nucleus but this failed to reach significance. No such reductions were seen in either the frontal or parietal cortices.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900052     DOI: 10.1016/0006-8993(88)90048-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  Hippocampal plasticity during the progression of Alzheimer's disease.

Authors:  E J Mufson; L Mahady; D Waters; S E Counts; S E Perez; S T DeKosky; S D Ginsberg; M D Ikonomovic; S W Scheff; L I Binder
Journal:  Neuroscience       Date:  2015-03-12       Impact factor: 3.590

2.  Mapping of human and macaque sensorimotor areas by integrating architectonic, transmitter receptor, MRI and PET data.

Authors:  K Zilles; G Schlaug; M Matelli; G Luppino; A Schleicher; M Qü; A Dabringhaus; R Seitz; P E Roland
Journal:  J Anat       Date:  1995-12       Impact factor: 2.610

3.  Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease.

Authors:  Guilian Tian; Qiongman Kong; Liching Lai; Abhik Ray-Chaudhury; Chien-liang G Lin
Journal:  J Neurochem       Date:  2010-02-27       Impact factor: 5.372

4.  Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias.

Authors:  J B Penney; W F Maragos; J T Greenamyre; D L Debowey; Z Hollingsworth; A B Young
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-04       Impact factor: 10.154

5.  Brain Activity of Benzoate, a D-Amino Acid Oxidase Inhibitor, in Patients With Mild Cognitive Impairment in a Randomized, Double-Blind, Placebo Controlled Clinical Trial.

Authors:  Hsien-Yuan Lane; Cheng-Hao Tu; Wei-Che Lin; Chieh-Hsin Lin
Journal:  Int J Neuropsychopharmacol       Date:  2021-05-18       Impact factor: 5.176

6.  Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging.

Authors:  Chieh-Hsin Lin; Hui-Ting Yang; Chih-Chiang Chiu; Hsien-Yuan Lane
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

7.  pLG72 levels increase in early phase of Alzheimer's disease but decrease in late phase.

Authors:  Chieh-Hsin Lin; Chih-Chiang Chiu; Chiung-Hsien Huang; Hui-Ting Yang; Hsien-Yuan Lane
Journal:  Sci Rep       Date:  2019-09-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.